Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitemarinuspharma.com
CategoryBioTech
Phone(203) 315-0566
Emailinfo@marinuspharm...
Employees
Founded2003
DescriptionNeurological disease treatment

Offices

Marinus Pharma.
21 Business Park Drive
Branford, CT, 06405
USA

People

Chairman of the Board & CEO
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Sr. Director, Clinical Development & Project Management
Show All People

Funding

TOTAL $52.4M
FUNDING TOTAL $52.4M
Series B, 5/2009
Canaan Partners
Domain Associates
Sofinnova Ventures
Foundation Medical Partners
$20M
Partial Close, 12/2012
$11.4M
Series C, 1/2013
Domain Associates
Canaan Partners
Sofinnova Ventures
Foundation Medical Partners
$21M

Tags

Marinus Pharmaceuticals

Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. The Company’s lead product is a first in class therapy for epilepsy. Marinus Pharmaceutica’s investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. The Company is located in Branford, Connecticut.

Recent Milestones

Videos

Screenshots

Sources

  1. Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com) [edit]
  2. SEC (sec.gov) [edit]
  3. Marinus Pharmaceuticals Raises $21M Funding in Series C Financing (finsmes.com) [edit]
Edit This Page
Last Edited 11/28/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy